A blood test measuring phospho-tau217 (p-tau217), a major component of Alzheimer’s disease-related tau tangles, was able to discriminate participants with Alzheimer’s disease from those with other neurodegenerative diseases.
Adults aged 40 years and older who reported a history of repetitive head impact had more symptoms of depression and difficulties in cognitive functioning, compared with those without such a history, according to a study in Neurology.
Virtual reality technology may one day replace traditional pencil-and-paper activities for cognitive training in older adults, suggests a study published online in the International Journal of Geriatric Psychiatry.
Stress-related disorders, such as post-traumatic stress disorder, are associated with a considerably higher risk of developing neurodegenerative diseases, according to a study published online in JAMA Neurology.
Biogen Inc and partner Eisai Co Ltd said they would abandon two late-stage trials testing experimental Alzheimer's treatment elenbecestat, months after scrapping trials of another drug for the memory-robbing disease.